Deep Track Capital’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
Other funds holding ATYR
VA
TM
TCM
SCM
TI
Deep Track Capital's ATYR Position: Q3 2022 in Review
Deep Track Capital sold out of aTyr Pharma (ATYR) in Q3 2022, closing a stake of 290,844 shares — an estimated $823K sold.
Deep Track Capital first reported a position in ATYR in Q4 2021 and held it in 3 quarters. The position peaked at $8.22M in Q4 2021. 33 funds tracked by Wall St. Rank hold ATYR as of Q3 2022.
- Deep Track Capital reported no remaining aTyr Pharma position as of Q3 2022 after selling out during the quarter.
- Deep Track Capital sold 290,844 aTyr Pharma shares in Q3 2022, an estimated $823K.
- Deep Track Capital first reported a position in aTyr Pharma in Q4 2021 and held it in 3 quarters.
- Deep Track Capital's aTyr Pharma position peaked at $8.22M in Q4 2021.
- 33 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2022.
Based on Deep Track Capital's 13F filing for Q3 2022, filed 14 Nov 2022.